Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,816 | 118 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,167 | 23 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $688.69 | 21 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $304.10 | 15 | $0 (2024) |
| Shire North American Group Inc | $229.17 | 7 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $228.21 | 8 | $0 (2021) |
| Alcon Vision LLC | $214.86 | 9 | $0 (2024) |
| RxSight Inc | $175.47 | 3 | $0 (2024) |
| TissueTech, Inc. | $158.10 | 1 | $0 (2018) |
| Oyster Point Pharma, Inc. | $157.31 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $112.11 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $624.11 | 27 | Bausch & Lomb Americas Inc. ($229.19) |
| 2023 | $344.68 | 10 | RxSight Inc ($136.42) |
| 2022 | $250.09 | 9 | Allergan, Inc. ($126.21) |
| 2021 | $294.81 | 17 | Kala Pharmaceuticals, Inc. ($108.49) |
| 2020 | $113.66 | 7 | Allergan, Inc. ($36.64) |
| 2019 | $694.07 | 19 | Bausch & Lomb, a division of Bausch Health US, LLC ($353.74) |
| 2018 | $1,238 | 26 | Allergan Inc. ($402.55) |
| 2017 | $257.08 | 3 | Allergan Inc. ($257.08) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Dry eyes | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Ophthalmology | ||||||
| 10/05/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Ophthalmology | ||||||
| 09/26/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: EYE CARE | ||||||
| 08/08/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Ophthalmology | ||||||
| 08/06/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Dry eyes | ||||||
| 07/18/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Ophthalmology | ||||||
| 07/01/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Ophthalmology | ||||||
| 06/24/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: SOLUTION/ DROPS | ||||||
| 06/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/17/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), INFUSE | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Ophthalmology | ||||||
| 05/15/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Ophthalmology | ||||||
| 05/07/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Dry eyes | ||||||
| 04/29/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Ophthalmology | ||||||
| 04/29/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Ophthalmology | ||||||
| 04/25/2024 | RxSight Inc | RXSIGHT INJECTOR HANDPIECE (Device), RXSIGHT CONTACT LENS, RXSIGHT LIGHT DELIVERY DEVICE (LDD) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/18/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Ophthalmology | ||||||
| 04/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Ophthalmology | ||||||
| 02/23/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Ophthalmology | ||||||
| 02/21/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Dry eyes | ||||||
| 02/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Ophthalmology | ||||||
| 02/15/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 136 | 139 | $27,427 | $10,839 |
| 2022 | 7 | 179 | 183 | $32,049 | $10,627 |
| 2021 | 8 | 472 | 539 | $92,975 | $35,181 |
| 2020 | 8 | 415 | 492 | $80,585 | $29,723 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 46 | 46 | $9,662 | $4,550 | 47.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 37 | 37 | $9,470 | $3,920 | 41.4% |
| 92250 | Photography of the retina | Office | 2023 | 40 | 40 | $5,860 | $1,231 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 16 | $2,435 | $1,138 | 46.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 65 | 65 | $14,956 | $4,574 | 30.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 28 | 28 | $7,804 | $2,541 | 32.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 31 | $2,373 | $1,166 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $2,040 | $1,038 | 50.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 14 | 14 | $2,246 | $550.78 | 24.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 17 | 17 | $1,585 | $408.47 | 25.8% |
| 92134 | Imaging of retina | Office | 2022 | 11 | 11 | $1,045 | $349.35 | 33.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 206 | 206 | $47,380 | $18,144 | 38.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 61 | 100 | $7,500 | $4,051 | 54.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2021 | 18 | 34 | $10,370 | $3,280 | 31.6% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 45 | 52 | $8,580 | $2,529 | 29.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 37 | $4,440 | $2,394 | 53.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 23 | 23 | $6,440 | $2,257 | 35.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 53 | 54 | $5,130 | $1,496 | 29.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 31 | 33 | $3,135 | $1,030 | 32.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 165 | 167 | $38,410 | $15,398 | 40.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 70 | 115 | $8,625 | $3,661 | 42.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2020 | 16 | 34 | $10,370 | $3,335 | 32.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 44 | $5,280 | $2,177 | 41.2% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 27 | 29 | $4,785 | $1,417 | 29.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 49 | 52 | $4,940 | $1,377 | 27.9% |
About Dr. Robert Reasoner, O.D
Dr. Robert Reasoner, O.D is a Optometrist healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2016. The National Provider Identifier (NPI) number assigned to this provider is 1548619026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Reasoner, O.D has received a total of $3,816 in payments from pharmaceutical and medical device companies, with $624.11 received in 2024. These payments were reported across 118 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,816).
As a Medicare-enrolled provider, Reasoner has provided services to 1,202 Medicare beneficiaries, totaling 1,353 services with total Medicare billing of $86,370. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Dayton, OH
- Active Since 06/06/2016
- Last Updated 06/06/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1548619026
Products in Payments
- RESTASIS (Drug) $517.96
- XIIDRA (Drug) $443.54
- VYZULTA (Drug) $382.77
- LUMIGAN (Drug) $358.13
- BIOTRUE (Device) $204.95
- Rhopressa (Drug) $190.66
- Prokera (Device) $158.10
- TYRVAYA (Drug) $157.31
- RXSIGHT CONTACT LENS (Device) $153.91
- VUITY (Drug) $153.74
- Rocklatan (Drug) $148.28
- INVELTYS (Drug) $108.49
- LOTEMAX SM (Drug) $96.65
- OXERVATE (Drug) $66.41
- INFUSE (Device) $62.91
- MIEBO (Drug) $62.00
- rhopressa (Drug) $55.67
- DURYSTA (Drug) $54.50
- XDEMVY (Drug) $51.73
- LOTEMAX GEL (Drug) $43.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Dayton
Catherine Mcdaniel, O.d, O.D
Optometrist — Payments: $37,525
Dr. Heath Gilbert, O.d, O.D
Optometrist — Payments: $4,926
Dr. Marc Gilbert, O.d, O.D
Optometrist — Payments: $3,246
Jason Andrus
Optometrist — Payments: $2,514
Chisom Chukwumerije
Optometrist — Payments: $2,090
Dr. Richard Fenton, O.d, O.D
Optometrist — Payments: $1,982